Volume 26, Issue 8 pp. 671-673

Carcinoma erysipeloides associated with anaplastic thyroid carcinoma

S. Y. Lee

S. Y. Lee

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
S. E. Chang

S. E. Chang

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
G. Y. Bae

G. Y. Bae

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
J. H. Choi

J. H. Choi

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
K. J. Sung

K. J. Sung

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
K. C. Moon

K. C. Moon

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
J. K. Koh

J. K. Koh

Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

Search for more papers by this author
First published: 07 July 2008
Citations: 21
: Sung-Eun Chang, Department of Dermatology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea. Tel: +82 2 2224 3460. Fax: +82 2 486 7831.E-mail: derm@http://www.amc.seoul.kr

Abstract

Cutaneous metastases from carcinoma of the thyroid gland are rare and carcinoma erysipeloides is even rarer. We present the clinical, histological, and immunohistochemical features of inflammatory erysipeloid metastases arising from an anaplastic carcinoma of the thyroid gland. In this case the anaplastic carcinoma probably transformed from a pre-existing, long-standing papillary carcinoma of the thyroid gland. Although visible inflammation is a hallmark of many benign skin disorders, it is not commonly present in cutaneous malignant metastases. As a result, the significance of a marked inflammatory changes in association with metastatic skin disease may not be recognized. Dermatologists need to be aware of the potential for inflammatory manifestations in cutaneous metastases from a thyroid carcinoma.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.